Amgen is one of the world’s leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses.
THANK YOU TO OUR CORPORATE PARTNERS
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products.
Astrazenca is a global, science-led biopharmaceutical business whose innovative medicines are used by millions of patients worldwide.
DaVita is a leading provider of dialysis services to patients with chronic kidney failure and end stage renal disease.
The primary responsibility of DCI is to perceive, initiate and provide comprehensive patient care for patients with End-Stage Renal Disease.
Fresenius Medical Care AG & Co. KGaA, is the world’s leading innovator in kidney care and the largest provider of dialysis products and services.
Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions.
Keryx brings innovative medicines to market that provide unique and meaningful advantages to people with renal disease and their healthcare providers.
Mallinckrodt, a specialty pharmaceutical company provides medicines to address unmet patient needs, stemming from 150 years of using our unique strengths, experience and expertise to help improve people’s lives.
The National Renal Administrators Association’s mission is to strengthen our kidney care community through education, advocacy and services.
Northwest Kidney Centers is a nonprofit, community-based organization with a mission to promote the optimal health, quality of life and independence of people with kidney disease through patient care, education and research.
NxStage Medical, Inc. is a leading medical technology company that develops, manufactures and markets innovative products for the treatment of end-stage renal disease (ESRD) and acute kidney failure. NxStage also has established a small number of dialysis clinics committed to the development of innovative care delivery models for patients with ESRD.
OneLegacy’s nearly 300 employees provide the complete range of services required to effectively recover donated organs, corneas and tissues, to support donor families, and to inspire our diverse communities to Donate Life.
The RSE is the primary nationwide provider of services supporting independent, regional or community-based providers of care for patients with chronic kidney disease.
Rockwell Medical is a fully-integrated biopharmaceutical company targeting end-stage renal and chronic kidney disease with innovative products and services for the treatment of iron deficiency anemia, secondary hyperparathyroidism and hemodialysis. Triferic, is the only FDA approved iron drug indicated to replace iron and maintain hemoglobin in hemodialysis patients suffering from anemia.
U.S. Renal Care serves more than 23,000 patients in 300 dialysis facilities in 31 states and the Territory of Guam with a unique business model, developing and operating dialysis centers in joint venture partnerships with leading local nephrologists.